Suanfarma Suanfarma

X

Find Atabecestat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Atabecestat
Also known as: Jnj-54861911, 1200493-78-2, Jnj-54861911-aaa, Atabecestat [inn], Rsc-385896, Atabecestat [usan]
Molecular Formula
C18H14FN5OS
Molecular Weight
367.4  g/mol
InChI Key
VLLFGVHGKLDDLW-SFHVURJKSA-N
FDA UNII
2834W8D6GK

Atabecestat is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates).
1 2D Structure

Atabecestat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
2.1.2 InChI
InChI=1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8,10H,1H3,(H2,21,24)(H,23,25)/t18-/m0/s1
2.1.3 InChI Key
VLLFGVHGKLDDLW-SFHVURJKSA-N
2.1.4 Canonical SMILES
CC1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F
2.1.5 Isomeric SMILES
C[C@]1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F
2.2 Other Identifiers
2.2.1 UNII
2834W8D6GK
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-pyridinecarboxamide, N-(3-((4s)-2-amino-4-methyl-4h-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyano-

2. Jnj-54861911

3. N-(3-((4s)-2-amino-4-methyl-4h-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyano-2-pyridinecarboxamide

2.3.2 Depositor-Supplied Synonyms

1. Jnj-54861911

2. 1200493-78-2

3. Jnj-54861911-aaa

4. Atabecestat [inn]

5. Rsc-385896

6. Atabecestat [usan]

7. 2834w8d6gk

8. (s)-n-(3-(2-amino-4-methyl-4h-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide

9. C18h14fn5os

10. 2-pyridinecarboxamide, N-(3-((4s)-2-amino-4-methyl-4h-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyano-

11. N-[3-[(4s)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide

12. N-[3-[(4s)-2-azanyl-4-methyl-1,3-thiazin-4-yl]-4-fluoranyl-phenyl]-5-cyano-pyridine-2-carboxamide

13. Atabecestat (usan/inn)

14. Atabecestat [usan:inn]

15. Unii-2834w8d6gk

16. Gtpl9963

17. Chembl3916243

18. Schembl12359105

19. Bdbm210070

20. Ex-a6458

21. Db15307

22. Rsc- 385896

23. Hy-109052

24. Cs-0031557

25. D11456

26. Us9270353, 17

27. H3c

28. N-(3-((4s)-2-amino-4-methyl-4h-1,3-thiazin-4-yl)-4-fluorophenyl)-5- Cyanopyridine-2-carboxamide

29. N-(3-((4s)-2-amino-4-methyl-4h-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyano-2-pyridinecarboxamide

2.4 Create Date
2012-11-30
3 Chemical and Physical Properties
Molecular Weight 367.4 g/mol
Molecular Formula C18H14FN5OS
XLogP32
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass367.09030942 g/mol
Monoisotopic Mass367.09030942 g/mol
Topological Polar Surface Area130 Ų
Heavy Atom Count26
Formal Charge0
Complexity659
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY